TerrAscend TSNDF
OTC TSNDF
$0.61 +0.05 (+8.93%)
At close: Aug 19, 2026 · 4:00 PM EDT

TerrAscend (TSNDF) Liabilities and Shareholders Equity (2021 - 2026)

TerrAscend (TSNDF) posted quarterly Liabilities and Shareholders Equity of $549.1 million for Q1 2026, down 8.6% year-over-year from $600.7 million in Q1 2025, and down 1.49% quarter-over-quarter from $557.4 million in Q4 2025.

TerrAscend (TSNDF) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has reported Liabilities and Shareholders Equity for 6 consecutive years, with $549.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 8.6% year-over-year to $549.1 million; the TTM figure through Mar 2026 stood at $2.2 billion (down 11.54% YoY), while the FY2025 annual figure was $557.4 million, down 8.21% from the prior year.
  • Liabilities and Shareholders Equity declined to $549.1 million in Q1 2026 per TSNDF's latest filing, from $557.4 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $1.0 billion in Q1 2022 and bottomed at $91000.0 in Q2 2023.
  • Historically, Liabilities and Shareholders Equity has averaged $646.4 million across 5 years, with a median of $656.9 million in 2024.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity slumped 99.99% — and 2024, when it soared 725442.86%.
  • TerrAscend's Liabilities and Shareholders Equity stood at $701.6 million in 2022, then decreased by 5.0% to $666.5 million in 2023, then decreased by 8.9% to $607.2 million in 2024, then fell by 8.21% to $557.4 million in 2025, then dropped by 1.49% to $549.1 million in 2026.
  • Business Quant data shows TSNDF's Liabilities and Shareholders Equity at $549.1 million in Q1 2026, $557.4 million in Q4 2025, and $555.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 39.86 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 6.18 Bn
10 TerrAscend 182.53 Mn 140.41 Mn 36.25 Mn 553.71 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 553.71 Mn
Mar 31, 2026 549.10 Mn
Dec 31, 2025 557.38 Mn
Sep 30, 2025 555.26 Mn
Jun 30, 2025 572.01 Mn
Mar 31, 2025 600.73 Mn
Dec 31, 2024 607.23 Mn
Sep 30, 2024 656.93 Mn
Jun 30, 2024 660.24 Mn
Mar 31, 2024 655.54 Mn
Dec 31, 2023 666.52 Mn
Sep 30, 2023 734.67 Mn
Jun 30, 2023 91,000.00
Mar 31, 2023 701.58 Mn
Dec 31, 2022 701.59 Mn
Sep 30, 2022 725.49 Mn
Jun 30, 2022 1.01 Bn
Mar 31, 2022 1.04 Bn
Dec 31, 2021 581.94 Mn